Effects of dendritic cells transfected with full length wild type P53 and modified by gastric cancer lysate on immune response

Abstract

To investigate the effects of dendritic cells (DCs) transfected with full length wild type p53 and modified by gastric cancer lysates on immune response, the wild type P53 was transducted to DCs with adenovirus, and the DCs were modified by gastric cancer lysates (Lywt-P53DC). The concentration of the surface molecules (B7-1, B7-2, MHC-I, MHC-II) of all DCs was determined by FACS, and the ability of the DCs to induce efficient and specific immunological response in anti-51Cr-labeled target cells studied. BALB/c mice model infected with DCs and Mk28 was established. CTL response in mice immunized with Lywt-p53DC and the effectiveness of Lywt-p53DC in the treatment of tumor-bearing mice was assayed. FACS revealed that the surface molecules of Lywt-P53 DC had a high expression: for B7-1 86.70%±0.07%, B7-2 18.77%±0.08%, MHC-I 87.20%±0.05%, MHC-II 56.70%±0.07%; The T lymphocytes had a specific CTL lysing ability induced by Lywt-P53DC with the CTL lysis rate being 81%. The immune protective effect of Lywt-p53DC group was more obvious than any other groups (P<0.05). The tumor diameter in Lywt-p53DC group was 3.10±0.31 mm, 2.73±0.23 mm, 3.70±0.07 mm on the day 13, 16 and 19, smaller than DC, wtp53DC and LyDC groups (P<0.05). On the other hand, the growth rate of tumor in Lywt-p53DC group was slower than any other groups (P<0.05). It was suggested that DCs transfected with wild type P53 and modified by gastric cancer lysates had specific CTL killing capability.

Keywords

dendritic cells / P53 / gastric cancer / immune response

References

[1] TakahashiT, NauM M, ChibaI, et al.. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 1989, 246: 491-491

[2] NikitinaE Y, ClarkJ I, vanBeynenJ, et al.. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients. Clin Cancer Res, 2001, 7(1): 127-127

[3] GabrilovichD I, CorakJ, CiernikI F, et al.. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res, 1997, 3: 483-483

[4] EuraM, ChikamatsuK, KatsuraF, et al.. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck. Clin. Cancer Res, 2000, 6: 979-979

[5] ThomsonS A, KhannaR, GardnerJ, et al.. Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc Natl Acad Sci (USA), 1995, 92: 5845-5845